Chemoinformaics analysis of 1-O-OCTYL 2-O-PROP-2-ENYL OXALATE
| Molecular Weight | 242.315 | nRot | 9 |
| Heavy Atom Molecular Weight | 220.139 | nRig | 2 |
| Exact Molecular Weight | 242.152 | nRing | 0 |
| Solubility: LogS | -1.49 | nHRing | 0 |
| Solubility: LogP | 1.691 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 39 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 39.5874 |
| nHD | 0 | BPOL | 27.2786 |
| QED | 0.386 |
| Synth | 2.867 |
| Natural Product Likeliness | 2.462 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.009 |
| HIA | 0.01 |
| CACO-2 | -4.247 |
| MDCK | 0.0000305 |
| BBB | 0.999 |
| PPB | 0.562047 |
| VDSS | 1.14 |
| FU | 0.434004 |
| CYP1A2-inh | 0.672 |
| CYP1A2-sub | 0.772 |
| CYP2c19-inh | 0.151 |
| CYP2c19-sub | 0.845 |
| CYP2c9-inh | 0.029 |
| CYP2c9-sub | 0.861 |
| CYP2d6-inh | 0.02 |
| CYP2d6-sub | 0.772 |
| CYP3a4-inh | 0.013 |
| CYP3a4-sub | 0.218 |
| CL | 6.085 |
| T12 | 0.753 |
| hERG | 0.016 |
| Ames | 0.457 |
| ROA | 0.955 |
| SkinSen | 0.958 |
| Carcinogencity | 0.833 |
| EI | 0.992 |
| Respiratory | 0.959 |
| NR-Aromatase | 0.007 |
| Antiviral | Yes |
| Prediction | 0.687969 |